PM
CYRX icon

Penbrook Management’s CryoPort CYRX Stock Holding History

Penbrook Management’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Buy
202,675
+16,900
+9% +$217K 2.03% 8
2026
Q1 		$1.54M Buy
185,775
+132,940
+252% +$1.2M 1.16% 22
2025
Q4 		$507K Buy
52,835
+65
+0.1% +$614 0.35% 56
2025
Q3 		$500K Sell
52,770
-42,170
-44% -$355K 0.35% 59
2025
Q2 		$636K Buy
94,940
+42,770
+82% +$265K 0.24% 76
2025
Q1 		$317K Sell
52,170
-400
-0.8% -$2.77K 0.24% 78
2024
Q4 		$409K Buy
52,570
+2,975
+6% +$22.2K 0.28% 72
2024
Q3 		$402K Buy
49,595
+16,465
+50% +$135K 0.26% 69
2024
Q2 		$229K Sell
33,130
-1,050
-3% -$14.1K 0.14% 88
2024
Q1 		$605K Sell
34,180
-600
-2% -$9.5K 0.38% 59
2023
Q4 		$539K Sell
34,780
-150
-0.4% -$1.96K 0.36% 63
2023
Q3 		$479K Hold
34,930
– – 0.35% 63
2023
Q2 		$603K Hold
34,930
– – 0.44% 52
2023
Q1 		$838K Buy
34,930
+2,515
+8% +$54.7K 0.64% 46
2022
Q4 		$562K Hold
32,415
– – 0.48% 55
2022
Q3 		$790K Sell
32,415
-1,300
-4% -$44.7K 0.68% 44
2022
Q2 		$1.04M Sell
33,715
-180
-0.5% -$4.79K 0.82% 33
2022
Q1 		$1.18M Hold
33,895
– – 0.77% 39
2021
Q4 		$2.01M Sell
33,895
-2,000
-6% -$138K 1.21% 20
2021
Q3 		$2.39M Sell
35,895
-200
-0.6% -$12.3K 1.48% 13
2021
Q2 		$2.28M Sell
36,095
-150
-0.4% -$8.44K 1.36% 18
2021
Q1 		$1.89M Hold
36,245
– – 1.36% 20
2020
Q4 		$1.59M Hold
36,245
– – 1.22% 24
2020
Q3 		$1.72M Sell
36,245
-18,675
-34% -$756K 1.49% 18
2020
Q2 		$1.66M Sell
54,920
-28,340
-34% -$631K 1.63% 13
2020
Q1 		$1.42M Sell
83,260
-290
-0.3% -$5.08K 1.82% 10
2019
Q4 		$1.38M Sell
83,550
-4,900
-6% -$72.9K 1.34% 21
2019
Q3 		$1.45M Sell
88,450
-2,700
-3% -$54.1K 1.57% 16
2019
Q2 		$1.67M Hold
91,150
– – 1.79% 10
2019
Q1 		$1.18M Buy
91,150
+7,740
+9% +$84.1K 1.22% 24
2018
Q4 		$920K Hold
83,410
– – 1.05% 32
2018
Q3 		$1.07M Hold
83,410
– – 1.02% 31
2018
Q2 		$1.32M Buy
83,410
+21,320
+34% +$227K 1.27% 25
2018
Q1 		$534K Buy
+62,090
New +$549K 0.53% 67

Other funds holding CYRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
KAM
Kopion Asset Management Mckinney, Texas $158M AUM 11.93% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
SSA
Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
AF
Avanza Fonder Stockholm, Sweden $4.59B AUM 41.03% 1-Year Est. Return

Penbrook Management's CYRX Position: Q2 2026 in Review

Penbrook Management increased its CryoPort (CYRX) stake by 9.1% in Q2 2026, buying an estimated $217K and bringing the position to 202,675 shares worth $3.18M. The position accounts for 2.03% of the portfolio, ranked #8.

Penbrook Management first reported a position in CYRX in Q1 2018 and has held it in 34 quarters since. 22 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • Penbrook Management held 202,675 shares of CryoPort worth $3.18M as of Q2 2026.
  • Penbrook Management bought 16,900 CryoPort shares in Q2 2026, an estimated $217K.
  • CryoPort made up 2.03% of Penbrook Management's portfolio in Q2 2026, its #8 holding.
  • Penbrook Management first reported a position in CryoPort in Q1 2018 and has held it in 34 quarters since.
  • 22 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Penbrook Management's 13F filing for Q2 2026, filed 23 Jul 2026.